nodes	percent_of_prediction	percent_of_DWPC	metapath
Aripiprazole—CYP3A7—Cyclosporine—focal segmental glomerulosclerosis	0.127	0.251	CbGbCtD
Aripiprazole—CYP3A7-CYP3A51P—Cyclosporine—focal segmental glomerulosclerosis	0.127	0.251	CbGbCtD
Aripiprazole—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.0952	0.188	CbGbCtD
Aripiprazole—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.062	0.122	CbGbCtD
Aripiprazole—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.0584	0.115	CbGbCtD
Aripiprazole—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0371	0.0733	CbGbCtD
Aripiprazole—Joint dislocation—Cyclosporine—focal segmental glomerulosclerosis	0.0173	0.0539	CcSEcCtD
Aripiprazole—Wound—Cyclosporine—focal segmental glomerulosclerosis	0.0113	0.035	CcSEcCtD
Aripiprazole—HTR2A—arteriole—focal segmental glomerulosclerosis	0.00909	0.211	CbGeAlD
Aripiprazole—Hallucination, visual—Cyclosporine—focal segmental glomerulosclerosis	0.00626	0.0195	CcSEcCtD
Aripiprazole—Hyperkeratosis—Cyclosporine—focal segmental glomerulosclerosis	0.00572	0.0178	CcSEcCtD
Aripiprazole—Swollen tongue—Cyclosporine—focal segmental glomerulosclerosis	0.00556	0.0173	CcSEcCtD
Aripiprazole—Rheumatoid arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00541	0.0168	CcSEcCtD
Aripiprazole—Uterine haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00468	0.0145	CcSEcCtD
Aripiprazole—Goitre—Cyclosporine—focal segmental glomerulosclerosis	0.00458	0.0142	CcSEcCtD
Aripiprazole—Pyelonephritis—Cyclosporine—focal segmental glomerulosclerosis	0.0043	0.0134	CcSEcCtD
Aripiprazole—Stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.0043	0.0134	CcSEcCtD
Aripiprazole—Altered state of consciousness—Cyclosporine—focal segmental glomerulosclerosis	0.00354	0.011	CcSEcCtD
Aripiprazole—Leukorrhea—Cyclosporine—focal segmental glomerulosclerosis	0.00349	0.0108	CcSEcCtD
Aripiprazole—Swelling face—Cyclosporine—focal segmental glomerulosclerosis	0.00343	0.0107	CcSEcCtD
Aripiprazole—Muscle contractions involuntary—Cyclosporine—focal segmental glomerulosclerosis	0.00338	0.0105	CcSEcCtD
Aripiprazole—Bursitis—Cyclosporine—focal segmental glomerulosclerosis	0.00338	0.0105	CcSEcCtD
Aripiprazole—Azotaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00307	0.00953	CcSEcCtD
Aripiprazole—Night sweats—Cyclosporine—focal segmental glomerulosclerosis	0.00303	0.00941	CcSEcCtD
Aripiprazole—HTR7—endothelium—focal segmental glomerulosclerosis	0.00299	0.0695	CbGeAlD
Aripiprazole—Micturition urgency—Cyclosporine—focal segmental glomerulosclerosis	0.00288	0.00895	CcSEcCtD
Aripiprazole—Gingival bleeding—Cyclosporine—focal segmental glomerulosclerosis	0.00288	0.00895	CcSEcCtD
Aripiprazole—Hypertriglyceridaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00285	0.00884	CcSEcCtD
Aripiprazole—Multiple fractures—Cyclosporine—focal segmental glomerulosclerosis	0.00281	0.00874	CcSEcCtD
Aripiprazole—Hirsutism—Cyclosporine—focal segmental glomerulosclerosis	0.00281	0.00874	CcSEcCtD
Aripiprazole—Fracture—Cyclosporine—focal segmental glomerulosclerosis	0.00281	0.00874	CcSEcCtD
Aripiprazole—Cerebration impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00278	0.00863	CcSEcCtD
Aripiprazole—Libido increased—Cyclosporine—focal segmental glomerulosclerosis	0.00269	0.00834	CcSEcCtD
Aripiprazole—Polyp—Cyclosporine—focal segmental glomerulosclerosis	0.00269	0.00834	CcSEcCtD
Aripiprazole—Vaginal discharge—Cyclosporine—focal segmental glomerulosclerosis	0.00269	0.00834	CcSEcCtD
Aripiprazole—Psoriasis—Cyclosporine—focal segmental glomerulosclerosis	0.0026	0.00808	CcSEcCtD
Aripiprazole—Folliculitis—Cyclosporine—focal segmental glomerulosclerosis	0.0026	0.00808	CcSEcCtD
Aripiprazole—CYP3A7-CYP3A51P—nephron tubule—focal segmental glomerulosclerosis	0.00255	0.0592	CbGeAlD
Aripiprazole—Blood triglycerides increased—Cyclosporine—focal segmental glomerulosclerosis	0.00249	0.00775	CcSEcCtD
Aripiprazole—Cyst—Cyclosporine—focal segmental glomerulosclerosis	0.00245	0.00759	CcSEcCtD
Aripiprazole—Peptic ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00245	0.00759	CcSEcCtD
Aripiprazole—Burning sensation—Cyclosporine—focal segmental glomerulosclerosis	0.00235	0.00731	CcSEcCtD
Aripiprazole—Myopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00233	0.00724	CcSEcCtD
Aripiprazole—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00227	0.00704	CcSEcCtD
Aripiprazole—Tongue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00225	0.00698	CcSEcCtD
Aripiprazole—H1F0—nephron tubule—focal segmental glomerulosclerosis	0.00222	0.0516	CbGeAlD
Aripiprazole—CYP3A7-CYP3A51P—cortex of kidney—focal segmental glomerulosclerosis	0.00218	0.0507	CbGeAlD
Aripiprazole—Skin ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.0021	0.00652	CcSEcCtD
Aripiprazole—Gingivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00208	0.00647	CcSEcCtD
Aripiprazole—Feeling hot—Cyclosporine—focal segmental glomerulosclerosis	0.00208	0.00647	CcSEcCtD
Aripiprazole—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00208	0.00647	CcSEcCtD
Aripiprazole—ADRA1B—kidney—focal segmental glomerulosclerosis	0.00207	0.0481	CbGeAlD
Aripiprazole—H1F0—kidney—focal segmental glomerulosclerosis	0.00195	0.0454	CbGeAlD
Aripiprazole—H1F0—cortex of kidney—focal segmental glomerulosclerosis	0.0019	0.0442	CbGeAlD
Aripiprazole—Disturbance in attention—Cyclosporine—focal segmental glomerulosclerosis	0.00189	0.00586	CcSEcCtD
Aripiprazole—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.00187	0.00582	CcSEcCtD
Aripiprazole—HTR2A—endothelium—focal segmental glomerulosclerosis	0.00187	0.0434	CbGeAlD
Aripiprazole—Amenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00186	0.00578	CcSEcCtD
Aripiprazole—Rhabdomyolysis—Cyclosporine—focal segmental glomerulosclerosis	0.00185	0.00574	CcSEcCtD
Aripiprazole—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00182	0.00566	CcSEcCtD
Aripiprazole—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00181	0.00562	CcSEcCtD
Aripiprazole—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.0018	0.00558	CcSEcCtD
Aripiprazole—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.0018	0.00558	CcSEcCtD
Aripiprazole—Dysmenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.0018	0.00558	CcSEcCtD
Aripiprazole—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0018	0.00558	CcSEcCtD
Aripiprazole—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.00551	CcSEcCtD
Aripiprazole—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.00551	CcSEcCtD
Aripiprazole—Lacrimation increased—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.00551	CcSEcCtD
Aripiprazole—Hyperuricaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00176	0.00547	CcSEcCtD
Aripiprazole—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.00176	0.00547	CcSEcCtD
Aripiprazole—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.00175	0.00544	CcSEcCtD
Aripiprazole—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00172	0.00533	CcSEcCtD
Aripiprazole—Creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00172	0.00533	CcSEcCtD
Aripiprazole—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.00172	0.00533	CcSEcCtD
Aripiprazole—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.00166	0.00517	CcSEcCtD
Aripiprazole—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.00163	0.00508	CcSEcCtD
Aripiprazole—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.00499	CcSEcCtD
Aripiprazole—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.00499	CcSEcCtD
Aripiprazole—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.00159	0.00493	CcSEcCtD
Aripiprazole—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.00158	0.0049	CcSEcCtD
Aripiprazole—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.00158	0.0049	CcSEcCtD
Aripiprazole—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.00156	0.00485	CcSEcCtD
Aripiprazole—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.00155	0.00482	CcSEcCtD
Aripiprazole—Blood urea increased—Cyclosporine—focal segmental glomerulosclerosis	0.00154	0.00479	CcSEcCtD
Aripiprazole—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00153	0.00477	CcSEcCtD
Aripiprazole—HTR1D—kidney—focal segmental glomerulosclerosis	0.00151	0.0351	CbGeAlD
Aripiprazole—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.00149	0.00464	CcSEcCtD
Aripiprazole—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.00149	0.00464	CcSEcCtD
Aripiprazole—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.00459	CcSEcCtD
Aripiprazole—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.00459	CcSEcCtD
Aripiprazole—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.00454	CcSEcCtD
Aripiprazole—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.00441	CcSEcCtD
Aripiprazole—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.00432	CcSEcCtD
Aripiprazole—HTR2B—cortex of kidney—focal segmental glomerulosclerosis	0.00137	0.0318	CbGeAlD
Aripiprazole—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00136	0.00424	CcSEcCtD
Aripiprazole—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00135	0.0042	CcSEcCtD
Aripiprazole—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.00134	0.00416	CcSEcCtD
Aripiprazole—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.00412	CcSEcCtD
Aripiprazole—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.00412	CcSEcCtD
Aripiprazole—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.00132	0.0041	CcSEcCtD
Aripiprazole—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.00132	0.0041	CcSEcCtD
Aripiprazole—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.00131	0.00408	CcSEcCtD
Aripiprazole—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.00401	CcSEcCtD
Aripiprazole—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.00397	CcSEcCtD
Aripiprazole—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.00394	CcSEcCtD
Aripiprazole—CHRM3—kidney—focal segmental glomerulosclerosis	0.00127	0.0294	CbGeAlD
Aripiprazole—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.00392	CcSEcCtD
Aripiprazole—ADRA2C—nephron tubule—focal segmental glomerulosclerosis	0.00126	0.0293	CbGeAlD
Aripiprazole—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.00391	CcSEcCtD
Aripiprazole—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.00125	0.00389	CcSEcCtD
Aripiprazole—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.00386	CcSEcCtD
Aripiprazole—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.00382	CcSEcCtD
Aripiprazole—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.00379	CcSEcCtD
Aripiprazole—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.00378	CcSEcCtD
Aripiprazole—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.00378	CcSEcCtD
Aripiprazole—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.00376	CcSEcCtD
Aripiprazole—HTR7—kidney—focal segmental glomerulosclerosis	0.0012	0.028	CbGeAlD
Aripiprazole—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.00369	CcSEcCtD
Aripiprazole—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.00366	CcSEcCtD
Aripiprazole—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00117	0.00363	CcSEcCtD
Aripiprazole—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00117	0.00363	CcSEcCtD
Aripiprazole—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.00349	CcSEcCtD
Aripiprazole—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.00345	CcSEcCtD
Aripiprazole—ADRA2C—kidney—focal segmental glomerulosclerosis	0.00111	0.0257	CbGeAlD
Aripiprazole—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.00338	CcSEcCtD
Aripiprazole—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00337	CcSEcCtD
Aripiprazole—ADRA2C—cortex of kidney—focal segmental glomerulosclerosis	0.00108	0.0251	CbGeAlD
Aripiprazole—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.00333	CcSEcCtD
Aripiprazole—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.00332	CcSEcCtD
Aripiprazole—CYP3A5—nephron tubule—focal segmental glomerulosclerosis	0.00105	0.0245	CbGeAlD
Aripiprazole—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.00326	CcSEcCtD
Aripiprazole—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.00325	CcSEcCtD
Aripiprazole—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.00321	CcSEcCtD
Aripiprazole—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.00319	CcSEcCtD
Aripiprazole—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.00312	CcSEcCtD
Aripiprazole—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000983	0.00305	CcSEcCtD
Aripiprazole—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.000959	0.00298	CcSEcCtD
Aripiprazole—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000953	0.00296	CcSEcCtD
Aripiprazole—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.000947	0.00294	CcSEcCtD
Aripiprazole—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.000933	0.0029	CcSEcCtD
Aripiprazole—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.000928	0.00288	CcSEcCtD
Aripiprazole—CYP3A5—kidney—focal segmental glomerulosclerosis	0.000926	0.0215	CbGeAlD
Aripiprazole—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000925	0.00287	CcSEcCtD
Aripiprazole—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00092	0.00286	CcSEcCtD
Aripiprazole—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.000914	0.00284	CcSEcCtD
Aripiprazole—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.000914	0.00284	CcSEcCtD
Aripiprazole—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.000912	0.00283	CcSEcCtD
Aripiprazole—CYP3A5—cortex of kidney—focal segmental glomerulosclerosis	0.000902	0.021	CbGeAlD
Aripiprazole—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.000901	0.0028	CcSEcCtD
Aripiprazole—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.000899	0.00279	CcSEcCtD
Aripiprazole—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.000896	0.00278	CcSEcCtD
Aripiprazole—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.000896	0.00278	CcSEcCtD
Aripiprazole—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000891	0.00277	CcSEcCtD
Aripiprazole—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.000891	0.00277	CcSEcCtD
Aripiprazole—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000889	0.00276	CcSEcCtD
Aripiprazole—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.000889	0.00276	CcSEcCtD
Aripiprazole—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.000872	0.00271	CcSEcCtD
Aripiprazole—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.000865	0.00269	CcSEcCtD
Aripiprazole—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.000862	0.00268	CcSEcCtD
Aripiprazole—ADRA2A—cortex of kidney—focal segmental glomerulosclerosis	0.00086	0.02	CbGeAlD
Aripiprazole—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.000858	0.00266	CcSEcCtD
Aripiprazole—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.000825	0.00256	CcSEcCtD
Aripiprazole—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.000823	0.00256	CcSEcCtD
Aripiprazole—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.000821	0.00255	CcSEcCtD
Aripiprazole—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000821	0.00255	CcSEcCtD
Aripiprazole—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000817	0.00254	CcSEcCtD
Aripiprazole—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.000815	0.00253	CcSEcCtD
Aripiprazole—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000811	0.00252	CcSEcCtD
Aripiprazole—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000807	0.00251	CcSEcCtD
Aripiprazole—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000805	0.0025	CcSEcCtD
Aripiprazole—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000791	0.00246	CcSEcCtD
Aripiprazole—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.000765	0.00238	CcSEcCtD
Aripiprazole—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.000762	0.00237	CcSEcCtD
Aripiprazole—HTR2A—kidney—focal segmental glomerulosclerosis	0.000751	0.0175	CbGeAlD
Aripiprazole—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000745	0.00231	CcSEcCtD
Aripiprazole—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00074	0.0023	CcSEcCtD
Aripiprazole—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.000737	0.00229	CcSEcCtD
Aripiprazole—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000725	0.00225	CcSEcCtD
Aripiprazole—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000719	0.00223	CcSEcCtD
Aripiprazole—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.000715	0.00222	CcSEcCtD
Aripiprazole—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000704	0.00219	CcSEcCtD
Aripiprazole—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.000701	0.00218	CcSEcCtD
Aripiprazole—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.0007	0.00217	CcSEcCtD
Aripiprazole—CYP3A4—kidney—focal segmental glomerulosclerosis	0.000695	0.0162	CbGeAlD
Aripiprazole—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.000694	0.00216	CcSEcCtD
Aripiprazole—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000687	0.00213	CcSEcCtD
Aripiprazole—CYP2D6—kidney—focal segmental glomerulosclerosis	0.000684	0.0159	CbGeAlD
Aripiprazole—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000673	0.00209	CcSEcCtD
Aripiprazole—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.000669	0.00208	CcSEcCtD
Aripiprazole—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000663	0.00206	CcSEcCtD
Aripiprazole—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00066	0.00205	CcSEcCtD
Aripiprazole—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.000657	0.00204	CcSEcCtD
Aripiprazole—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000653	0.00203	CcSEcCtD
Aripiprazole—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000644	0.002	CcSEcCtD
Aripiprazole—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000642	0.00199	CcSEcCtD
Aripiprazole—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00064	0.00199	CcSEcCtD
Aripiprazole—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000624	0.00194	CcSEcCtD
Aripiprazole—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000619	0.00192	CcSEcCtD
Aripiprazole—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000617	0.00192	CcSEcCtD
Aripiprazole—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000608	0.00189	CcSEcCtD
Aripiprazole—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000608	0.00189	CcSEcCtD
Aripiprazole—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000608	0.00189	CcSEcCtD
Aripiprazole—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000606	0.00188	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000604	0.00188	CcSEcCtD
Aripiprazole—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000601	0.00187	CcSEcCtD
Aripiprazole—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000595	0.00185	CcSEcCtD
Aripiprazole—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000588	0.00183	CcSEcCtD
Aripiprazole—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000583	0.00181	CcSEcCtD
Aripiprazole—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000583	0.00181	CcSEcCtD
Aripiprazole—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000579	0.0018	CcSEcCtD
Aripiprazole—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000572	0.00178	CcSEcCtD
Aripiprazole—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000571	0.00177	CcSEcCtD
Aripiprazole—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000566	0.00176	CcSEcCtD
Aripiprazole—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000564	0.00175	CcSEcCtD
Aripiprazole—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.00056	0.013	CbGeAlD
Aripiprazole—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000556	0.00173	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000531	0.00165	CcSEcCtD
Aripiprazole—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000527	0.00164	CcSEcCtD
Aripiprazole—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000524	0.00163	CcSEcCtD
Aripiprazole—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00052	0.00161	CcSEcCtD
Aripiprazole—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000518	0.00161	CcSEcCtD
Aripiprazole—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000513	0.00159	CcSEcCtD
Aripiprazole—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000507	0.00157	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000503	0.00156	CcSEcCtD
Aripiprazole—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000503	0.00156	CcSEcCtD
Aripiprazole—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000499	0.00155	CcSEcCtD
Aripiprazole—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000499	0.00155	CcSEcCtD
Aripiprazole—ABCB1—kidney—focal segmental glomerulosclerosis	0.000492	0.0114	CbGeAlD
Aripiprazole—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000481	0.00149	CcSEcCtD
Aripiprazole—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.000479	0.0111	CbGeAlD
Aripiprazole—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000477	0.00148	CcSEcCtD
Aripiprazole—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000463	0.00144	CcSEcCtD
Aripiprazole—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000461	0.00143	CcSEcCtD
Aripiprazole—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000461	0.00143	CcSEcCtD
Aripiprazole—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00043	0.00133	CcSEcCtD
Aripiprazole—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000418	0.0013	CcSEcCtD
Aripiprazole—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000413	0.00128	CcSEcCtD
Aripiprazole—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000399	0.00124	CcSEcCtD
Aripiprazole—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000386	0.0012	CcSEcCtD
Aripiprazole—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000371	0.00115	CcSEcCtD
Aripiprazole—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000368	0.00114	CcSEcCtD
Aripiprazole—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000367	0.00114	CcSEcCtD
Aripiprazole—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000365	0.00113	CcSEcCtD
Aripiprazole—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000346	0.00108	CcSEcCtD
Aripiprazole—CHRM5—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.14e-05	0.000245	CbGpPWpGaD
Aripiprazole—ADRA2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	3.12e-05	0.000244	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.12e-05	0.000243	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3.12e-05	0.000243	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.11e-05	0.000243	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.11e-05	0.000243	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.1e-05	0.000242	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.1e-05	0.000242	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—CTGF—focal segmental glomerulosclerosis	3.1e-05	0.000242	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.1e-05	0.000242	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.09e-05	0.000241	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.07e-05	0.00024	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.06e-05	0.000239	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.05e-05	0.000238	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.05e-05	0.000238	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.04e-05	0.000237	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.03e-05	0.000236	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.02e-05	0.000235	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.01e-05	0.000235	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.99e-05	0.000233	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—LPL—focal segmental glomerulosclerosis	2.97e-05	0.000232	CbGpPWpGaD
Aripiprazole—ADRA2C—Hemostasis—TGFB1—focal segmental glomerulosclerosis	2.95e-05	0.00023	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.95e-05	0.00023	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.93e-05	0.000229	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.91e-05	0.000227	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.91e-05	0.000227	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.9e-05	0.000226	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.89e-05	0.000225	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—LPL—focal segmental glomerulosclerosis	2.89e-05	0.000225	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.88e-05	0.000225	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.88e-05	0.000225	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.88e-05	0.000224	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.87e-05	0.000224	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.86e-05	0.000223	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.86e-05	0.000223	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.86e-05	0.000223	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.86e-05	0.000223	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.85e-05	0.000223	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.85e-05	0.000222	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.84e-05	0.000221	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.84e-05	0.000221	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.81e-05	0.000219	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.8e-05	0.000219	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.8e-05	0.000218	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.76e-05	0.000215	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.75e-05	0.000214	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.72e-05	0.000212	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.71e-05	0.000211	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.69e-05	0.00021	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.66e-05	0.000208	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.66e-05	0.000208	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.66e-05	0.000208	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.66e-05	0.000207	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	2.66e-05	0.000207	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.64e-05	0.000206	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.63e-05	0.000205	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.62e-05	0.000204	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.61e-05	0.000204	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.61e-05	0.000203	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.6e-05	0.000203	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.6e-05	0.000203	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.6e-05	0.000203	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.6e-05	0.000202	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.59e-05	0.000202	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.58e-05	0.000201	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.57e-05	0.000201	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.57e-05	0.0002	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.56e-05	0.0002	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.56e-05	0.000199	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—LPL—focal segmental glomerulosclerosis	2.55e-05	0.000199	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.55e-05	0.000199	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—AGT—focal segmental glomerulosclerosis	2.54e-05	0.000198	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.51e-05	0.000196	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	2.5e-05	0.000195	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.49e-05	0.000194	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.49e-05	0.000194	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.48e-05	0.000194	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.48e-05	0.000193	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.48e-05	0.000193	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.47e-05	0.000193	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—AGT—focal segmental glomerulosclerosis	2.47e-05	0.000193	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.45e-05	0.000191	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.45e-05	0.000191	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.45e-05	0.000191	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.43e-05	0.00019	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.41e-05	0.000188	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.41e-05	0.000188	CbGpPWpGaD
Aripiprazole—ADRA2A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	2.4e-05	0.000187	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.38e-05	0.000186	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.37e-05	0.000185	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.36e-05	0.000184	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.35e-05	0.000183	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—LPL—focal segmental glomerulosclerosis	2.34e-05	0.000183	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	2.34e-05	0.000182	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.29e-05	0.000179	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.28e-05	0.000178	CbGpPWpGaD
Aripiprazole—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	2.27e-05	0.000177	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.26e-05	0.000176	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.26e-05	0.000176	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.25e-05	0.000175	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.23e-05	0.000174	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.22e-05	0.000173	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.22e-05	0.000173	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.22e-05	0.000173	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.21e-05	0.000173	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.21e-05	0.000172	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.21e-05	0.000172	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	2.2e-05	0.000172	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.2e-05	0.000172	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.2e-05	0.000171	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.2e-05	0.000171	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.19e-05	0.000171	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—AGT—focal segmental glomerulosclerosis	2.18e-05	0.00017	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.18e-05	0.00017	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.17e-05	0.00017	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.15e-05	0.000168	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.15e-05	0.000168	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.15e-05	0.000168	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.15e-05	0.000168	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—LPL—focal segmental glomerulosclerosis	2.15e-05	0.000167	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.14e-05	0.000167	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.14e-05	0.000167	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.13e-05	0.000166	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.12e-05	0.000165	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.12e-05	0.000165	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.11e-05	0.000165	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.11e-05	0.000164	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.09e-05	0.000163	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.07e-05	0.000162	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.06e-05	0.000161	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.06e-05	0.000161	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.05e-05	0.00016	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.04e-05	0.000159	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.04e-05	0.000159	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.04e-05	0.000159	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.03e-05	0.000158	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.03e-05	0.000158	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.03e-05	0.000158	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.02e-05	0.000158	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.02e-05	0.000158	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.02e-05	0.000158	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—AGT—focal segmental glomerulosclerosis	2e-05	0.000156	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2e-05	0.000156	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2e-05	0.000156	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2e-05	0.000156	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.97e-05	0.000154	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.96e-05	0.000153	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.96e-05	0.000153	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—ALB—focal segmental glomerulosclerosis	1.95e-05	0.000152	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.91e-05	0.000149	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.91e-05	0.000149	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—ALB—focal segmental glomerulosclerosis	1.89e-05	0.000148	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.88e-05	0.000147	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.88e-05	0.000146	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.87e-05	0.000146	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.86e-05	0.000145	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.84e-05	0.000144	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.84e-05	0.000143	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—AGT—focal segmental glomerulosclerosis	1.84e-05	0.000143	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.83e-05	0.000143	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.83e-05	0.000142	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.81e-05	0.000141	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.81e-05	0.000141	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.8e-05	0.000141	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.73e-05	0.000135	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.71e-05	0.000134	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.7e-05	0.000133	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.7e-05	0.000133	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.7e-05	0.000132	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.7e-05	0.000132	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.7e-05	0.000132	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.69e-05	0.000132	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.69e-05	0.000132	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.68e-05	0.000131	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—ALB—focal segmental glomerulosclerosis	1.68e-05	0.000131	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.68e-05	0.000131	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.67e-05	0.00013	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.67e-05	0.00013	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.65e-05	0.000129	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.64e-05	0.000128	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	1.64e-05	0.000128	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.63e-05	0.000127	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.62e-05	0.000127	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	1.62e-05	0.000126	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.6e-05	0.000125	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.59e-05	0.000124	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.56e-05	0.000122	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.55e-05	0.000121	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.55e-05	0.000121	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—ALB—focal segmental glomerulosclerosis	1.54e-05	0.00012	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.53e-05	0.00012	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	1.53e-05	0.000119	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.46e-05	0.000114	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.44e-05	0.000112	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	1.44e-05	0.000112	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.44e-05	0.000112	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.42e-05	0.00011	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.41e-05	0.00011	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—ALB—focal segmental glomerulosclerosis	1.41e-05	0.00011	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.41e-05	0.00011	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.4e-05	0.00011	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.4e-05	0.000109	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.4e-05	0.000109	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.39e-05	0.000108	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.39e-05	0.000108	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.39e-05	0.000108	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	1.39e-05	0.000108	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.36e-05	0.000106	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.34e-05	0.000104	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.33e-05	0.000104	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.32e-05	0.000103	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.31e-05	0.000102	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	1.31e-05	0.000102	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.3e-05	0.000101	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.29e-05	0.000101	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.28e-05	9.96e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.26e-05	9.85e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.26e-05	9.8e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.25e-05	9.75e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.22e-05	9.48e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.2e-05	9.39e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.2e-05	9.33e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.19e-05	9.26e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.1e-05	8.6e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.09e-05	8.46e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.08e-05	8.45e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.08e-05	8.44e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.08e-05	8.42e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.08e-05	8.39e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.07e-05	8.36e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.07e-05	8.31e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	1.06e-05	8.3e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.06e-05	8.29e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.04e-05	8.07e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.03e-05	8.03e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	1e-05	7.82e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1e-05	7.81e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	9.98e-06	7.79e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.87e-06	7.7e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.86e-06	7.69e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.09e-06	7.09e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.94e-06	6.98e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.92e-06	6.96e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.9e-06	6.94e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.87e-06	6.92e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.78e-06	6.85e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.76e-06	6.83e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	8.54e-06	6.66e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.14e-06	6.35e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	6.55e-06	5.11e-05	CbGpPWpGaD
